Tradestie Institutional Equity Comparison Engine

HHS vs CNCG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

HHS Overall Edge

HHS Captures Institutional Edge (2โ€“1 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Harte Hanks, Inc. (HHS) driven by superior Valuation, Growth & Margin while CNCG counters with relative strength in Momentum & Technical. Fundamentally, HHS trades at 14.3x Forward P/E with -3.2% operating margin (-1.7% YoY revenue) versus CNCG at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, HHS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against CNCG sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner HHS
HHS 14.3x vs CNCG N/M Fwd P/E
Growth & Margin Winner HHS
Op Margin -3.2% vs N/A ยท YoY -1.7% vs N/A
Momentum & Technical Winner CNCG
1Y +8.8% vs +109.8% ยท 52W Pos 69% vs 82%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
1M Return -10.49%
1Y Return +8.78%
Forward P/E 14.3x
Unified AI Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
CNCG US Equity
CNCG
Institutional Equity
$32.28
+0.59% 1D
Market Cap N/A
1M Return -6.66%
1Y Return +109.81%
Forward P/E N/M
Unified AI Score
56.7 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 50.0 Mom 54.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: HHS +8.78% CNCG +109.81% Spread: +143.34 pp (CNCG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
HHS TTM Op. Margin: -3.2% CNCG TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HHS vs CNCG. Trailing 12-month operating profitability (HHS -3.2% vs CNCG N/A) and valuation multiples (HHS 14.3x vs CNCG N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: HHS (9) vs CNCG (1)
Institutional Metric HHS CNCG Criterion Row Winner
Market Capitalization Scale $30.0M N/A Larger Scale HHS
Trailing P/E Ratio Valuation 14.3x N/M Lower Multiple HHS
Forward P/E Ratio Valuation 14.3x N/M Lower Multiple HHS
Revenue Growth (YoY) Growth -1.7% N/A Higher Growth HHS
Operating Margin (TTM) Profitability -3.2% N/A Higher Margin HHS
Net Profit Margin Profitability -3.7% N/A Higher Margin HHS
Return on Equity (ROE) Capital Efficiency -30.4% N/A Higher ROE HHS
52-Week Range Position Momentum 69% ($2โ€“$5) 82% ($9โ€“$38) Stronger Trend CNCG
Beta / 30D Volatility Risk Regime 0.49ฮฒ ยท 46% Vol 0.32ฮฒ ยท 78% Vol Lower Realized Risk HHS
Unified Institutional Score Composite Signal 61.8 / 100 (BUY) 56.7 / 100 (HOLD) Higher Composite HHS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full HHS vs CNCG Buy Guide
HHS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live HHS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CNCG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CNCG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither HHS nor CNCG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.